Published Paper Details:

The contemporary trend in the advancement of oral medicinal products (MP) involves the amalgamation of targeted transport and enhancement of the release profile of the active pharmaceutical ingredient (API). A prominent strategy to actualize this concept entails the development of floating gastroretentive delivery systems, facilitating prolonged residence of the dosage form (DF) within the gastric contents. This discourse delves into the nomenclature of polymeric excipients (Es) employed in the fabrication of floating drug delivery systems (FDDS). Drawing upon findings presented in scholarly publications, predominant categories of polymers, their inherent properties, and their specific roles in diverse technological methodologies for achieving buoyancy are elucidated. Furthermore, the text delineates approaches for modifying the release of APIs within these systems and explicates the corresponding polymeric excipients utilized for such modifications. The prevailing tendencies in polymer utilization within the realm of floating dosage forms (FDF) are discussed, culminating in overarching conclusions regarding the future prospects of this trajectory